Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03648918 · ClinicalTrials.gov registry record

Genetics Of Autoimmunity In Type I Diabetes

A clinical trial of Diabetes Mellitus and Diabetes Mellitus, Type 1, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT03648918 is a study of Diabetes Mellitus and Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 4,000 participants, above the 1,848-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03648918, a study of Diabetes Mellitus and Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood draw, a brief medical history questionnaire and measurements of height and weight. Some participants will be asked to return for annual follow-up visits for 10 years.

Interventions

  • OTHER Blood Collection

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2001-08
Est. Completion 2050-01

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT03648918

The ClinicalTrials.gov registry entry for NCT03648918 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,848-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (116% higher). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Blood Collection is the first listed.

NCT03648918 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03648918 about?

NCT03648918 is a clinical study titled "Genetics Of Autoimmunity In Type I Diabetes". The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood ...

What is the current status of trial NCT03648918?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2001-08. Estimated completion is 2050-01.

What conditions does trial NCT03648918 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Type1diabetes, Type1 Diabetes Mellitus.

What interventions are being tested in trial NCT03648918?

The interventions under investigation include: Blood Collection (OTHER).

Who is sponsoring clinical trial NCT03648918?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03648918 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.